BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:MTEI Seminar by Dr. Evangelos Syrigos\, University of Zurich
DTSTART:20140331T120000
DTEND:20140331T133000
DTSTAMP:20260427T200115Z
UID:e2f6ddd62d6e2dac1d0e5ab9fdf08dc6c6aaa760925a41f0014ccd2a
CATEGORIES:Conferences - Seminars
DESCRIPTION:Dr. Evangelos Syrigos\, University of Zurich\n"Managerial Eval
 uation of Resource Value – Standalone Value\, Complementary Resources\, 
 and Market Structure"Abstract :\nResource value is among the most debated 
 concepts in the resource-based theory. In this paper\, we test recent argu
 ments that resource value is a function of a resource’s ex ante standalo
 ne value\, the presence of complementary resources\, and demand-side facto
 rs using a dataset of all patents filed by the 33 largest pharmaceutical c
 orporations in the US market during 1980-1985.  In line with our predicti
 ons\, we find a positive direct effect of standalone technological value o
 f a new patented molecule. We further find that the level of demand and th
 e firm’s position in the therapeutic class positively moderate the influ
 ence of a patented molecules standalone value on the likelihood of that mo
 lecule being further developed through clinical trials. Contrary to our pr
 edictions\, we find that scientific and technological strength negatively 
 moderate this relationship\, a finding that suggests negative complementar
 ity in the form of increased selectiveness in further developing molecules
  into drugs.
LOCATION:ODY 4.03 - VIP Room http://plan.epfl.ch/?zoom=20&recenter_y=58638
 00.12869&recenter_x=731560.22521&layerNodes=fonds\,batiments\,labels\,info
 rmation\,parkings_publics\,arrets_metro&floor=4&q=ODY_4.03
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR